Veterinary Drug
The one-stop service platform for veterinary drugs—GLP/GCP—is a specialized service provider that offers an integrated solution—from non-clinical evaluation to clinical trials and registration submission—aligned with both the Ministry of Agriculture and Rural Affairs’ GLP/GCP standards for veterinary drugs and the international OECD GLP standards, all centered around the entire R&D process for veterinary pharmaceuticals. Its core mission is to address key challenges faced by companies, such as lengthy R&D cycles, high compliance barriers, and fragmented resources.
1. Core Positioning
Centered on the principles of “compliance first, technology-driven, and full-chain services,” we focus on product categories such as small-molecule pet drugs, biological products, and topical formulations. We provide domestic and international pet pharmaceutical companies and research institutions with one-stop technical support—from candidate compound screening to new veterinary drug registration approval—helping products swiftly pass non-clinical safety evaluations and clinical trials, shortening the R&D cycle, and reducing application risks.
2. Core Features
Module | Core service content |
GLP Non-clinical Evaluation | 1. Toxicological Studies: Acute/Long-term Toxicity, Genotoxicity, Reproductive Toxicity, Local Toxicity, Safety Pharmacology 2. Pharmacokinetic/Toxicokinetic Studies: LC-MS/MS for Drug Concentration Measurement and Metabolite Identification 3. Pharmacodynamic Validation: Efficacy validation in canine and feline models (e.g., diabetes, skin inflammation) 4. Drug Compatibility and Stability Evaluation |
GCP Clinical Trial | 1. Clinical Trial Engagement: Conducting Efficacy Studies in Healthy Animals 2. Clinical Safety Trial: Monitoring Service Center Trial, Evaluating Drug Efficacy and Resistance 3. Pharmacokinetic/Bioequivalence Studies: Determining Drug Concentrations in Animals 4. Monitoring Period Study: Clearly determine the residue levels of the drug in animal tissues. |
Registration and Filing | 1. Data organization: Prepare clinical (clinical trial reports) and application materials for veterinary drugs submitted to the Ministry of Agriculture and Rural Affairs. 2. On-site verification support: Addressing technical issues during the registration process 3. Product Data Submission: Provide standardized data that complies with OCCD standards to facilitate a smooth application process. |
3. Animal facilities
 |  |
Animal facilities | Barrier Animal Facility |
 |  |
Barrier Animal Area | Biosafety cabinet |
4. Research Experience
We have completed several non-clinical veterinary drug studies, covering acute toxicity studies for companion animal medications, subchronic toxicity studies for livestock and poultry drugs, and genotoxicity studies. We provide veterinary pharmaceutical companies with submission reports that meet the requirements of the Ministry of Agriculture and Rural Affairs, thereby helping their products obtain rapid approval. We also conduct GCP clinical trials for veterinary drugs, assisting sponsor in addressing challenges such as clinical protocol design and data statistical analysis, and tailoring our services to meet the R&D needs of popular categories like pet dewormers and anti-inflammatory agents.
More fields
As an institution in Shaanxi Province that has obtained NMPA drug GLP certification and completed its qualification re-examination and scope expansion in 2024, Guorui Yinuo has built a “global + domestic” dual-compliance service capability in the pharmaceutical sector.
The one-stop service platform for veterinary drugs—GLP/GCP—is a specialized service provider that offers an integrated solution—from non-clinical evaluation to clinical trials and registration submission—aligned with both the Ministry of Agriculture and Rural Affairs’ GLP/GCP standards for veterinary drugs and the international OECD GLP standards, covering the entire R&D process for veterinary pharmaceuticals. At its core, this platform addresses the key pain points faced by companies, including long R&D cycles, high compliance barriers, and fragmented resources.
As the only organization in the Northwest region to have obtained OECD GLP certification in the pesticide field, Guorui Yinuo passed the international assessment with a zero-defect record. Relying on its compliance credentials, comprehensive technological capabilities across the entire value chain, and high-standard laboratory platform, Guorui Yinuo provides integrated solutions for global pesticide companies—from research and development all the way through registration.
Relying on the OECD GLP zero-defect certification qualification, chemical test data can be globally recognized and simultaneously comply with both domestic and international chemical regulatory requirements as well as relevant requirements of the Ministry of Ecology and Environment, efficiently supporting needs such as chemical registration and export declarations.
Shaanxi Guorui Xinchuang Medical Technology Co., Ltd. is an independent, third-party clinical preclinical safety evaluation research institution for medical devices. It was registered and established in June 2020 in the Airport New City and is currently the most comprehensive medical device safety evaluation institution in Northwest China. The company primarily provides product safety evaluation services to R&D enterprises specializing in Class II and Class III medical devices.
A full-process technology empowerment platform from target discovery to IND submission
Early Toxicity Prediction and Screening
Early toxicity screening is an essential and indispensable step in the new drug development process. Early termination of compounds that show no development potential can save sponsor substantial amounts of manpower, resources, and time. We offer sponsor comprehensive early toxicity screening services, including early genotoxicity assessment, early general toxicity assessment, and early reproductive and developmental toxicity assessment.
We are equipped with specialized instruments and devices, including flow cytometers, microplate readers, fluorescence microscopes, and PCR machines. These resources enable us to establish animal models for diseases affecting the tumor, cardiovascular, respiratory, metabolic, and urinary systems, and to conduct comprehensive and systematic preclinical studies on drug efficacy and mechanisms at multiple levels.
Contact phone number
Ms. Li:+86 15760970681
Mr. Su:+86 19991001701
Landline:+86-29-33656828
Company Address
4th Floor, Unit C. Building 9. Small and Medium-sized
Enterprise Park, Airport Industrial Zone Airport New Ciy,Xixian New Area, Shaanxi Province
©2026 Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd.
WhatsApp：8613940397353
Email：hr-xian@grglp.com
Landline：862933656828
Mr. Su：8619991001701
Ms. Li：8615760970681